Back
Ladder Capital Corp. Vs. Zenas BioPharma, Inc. Industry Stock Comparison
Sell
33
LADR
Ladder Capital Corp.
Last Price:
$9.78
Seasonality Move:
5.3%
Sell
47
ZBIO
Zenas BioPharma, Inc.
Last Price:
$21.41
Seasonality Move:
-5.74%
Sell
33
Ladder Capital Corp. (LADR)
is a Sell
Is Ladder Capital Corp. a Buy, Sell or Hold?
-
The current Ladder Capital Corp. [LADR] share price is $9.78. The Score for LADR is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
LADR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Zenas BioPharma, Inc. (ZBIO)
is a Sell
Is Zenas BioPharma, Inc. a Buy, Sell or Hold?
-
The current Zenas BioPharma, Inc. [ZBIO] share price is $21.46. The Score for ZBIO is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
ZBIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LADR Stock Price Chart
What is Ladder Capital Corp.'s stock price today?
-
The Ladder Capital Corp. share price today is $9.78Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LADR is experiencing buying pressure, which is a positive indicator for future bullish movement.
ZBIO Stock Price Chart
What is Zenas BioPharma, Inc.'s stock price today?
-
The Zenas BioPharma, Inc. share price today is $21.46Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ZBIO is experiencing slight buying pressure.
LADR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 39.37 | Sell |
| Chaikin Money Flow: | 469333 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.82 - 10.28) | Sell |
| Bollinger Bands (100): | (10.19 - 11.15) | Sell |
ZBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.24 | Sell |
| Relative Strength Index (14 RSI): | 45.8 | Sell |
| Chaikin Money Flow: | 706453 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.73 - 25.57) | Sell |
| Bollinger Bands (100): | (20.02 - 35.96) | Sell |
LADR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.83 | Sell |
| 20-day SMA: | 9.96 | Sell |
| 50-day SMA: | 10.36 | Sell |
| 200-day SMA: | 10.86 | Sell |
| 8-day EMA: | 9.82 | Sell |
| 20-day EMA: | 9.97 | Sell |
| 50-day EMA: | 10.27 | Sell |
| 200-day EMA: | 10.74 | Sell |
ZBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.4 | Buy |
| 20-day SMA: | 22.52 | Sell |
| 50-day SMA: | 23.03 | Sell |
| 200-day SMA: | 23.22 | Sell |
| 8-day EMA: | 20.67 | Buy |
| 20-day EMA: | 21.95 | Sell |
| 50-day EMA: | 23.64 | Sell |
| 200-day EMA: | 23.02 | Sell |
Ladder Capital Corp. Earnings Growth & LADR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.01 per share, an increase this year of $0.12 per share, and an increase next year of $0.18 per share.
Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.38 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.73 per share, and an increase next year of $0.23 per share.
Ladder Capital Corp. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zenas BioPharma, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||